Axogen Inc vs iShares MSCI Japan ETF — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while iShares MSCI Japan ETF trades at $93.71. Which is the better fit depends on your goals.
| AXGN | EWJ | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $46.19 | $96.97 |
52-Week Low | $11.28 | $71.69 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
EWJ, the iShares MSCI Japan ETF, trades at $92.72, down 1.94% on the day. Technical indicators are mixed, with a neutral overall signal but bullish moving averages, while key financial ratios are unavailable. The ETF provides exposure to Japanese equities but faces headwinds from yen weakness, as recent news highlights currency hedging strategies and potential government intervention to support the yen.
The outlook for EWJ is influenced by Japan's equity market performance and currency dynamics. Opportunities include diversification benefits and potential gains if the Nikkei 225 rebounds, but risks stem from yen depreciation, geopolitical tensions, and domestic economic policies. Investors should weigh currency-hedged alternatives amid ongoing volatility.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →